Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

HUS Helsinki University Hospital

Research site

Finland Haartmaninkatu 4, 00029 Helsinki, Finland

  • Chronic kidney disease · Hormone-refractory prostate cancer · Prostate cancer metastatic
  • Adult patients

About Specializations

HUS Helsinki University Hospital in Helsinki, Finland specialises in clinical trials of conditions such as Chronic kidney disease, Hormone-refractory prostate cancer, Prostate cancer metastatic, Type 1 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms (Oncology)

The Department of Urology at HUS Helsinki University Hospital is conducting research focused on metastatic castration‑resistant prostate cancer, aiming to improve treatment outcomes by testing a new combination of targeted agents.

  • PARP inhibitor plus androgen receptor blocker
  • Assessment of DNA‑damage response subgroups
  • Extension of radiographic progression‑free survival

These studies seek to establish more effective therapeutic options for patients with advanced prostate cancer.

Nutritional and Metabolic Diseases

In the same department, investigators are evaluating renal protection strategies in adults with type 1 diabetes and chronic kidney disease, using a novel drug combination that includes dapagliflozin.

  • Reduction of albuminuria
  • Prevention of renal injury
  • Safety of combined therapy

The goal is to improve kidney health and slow disease progression for individuals living with diabetes‑related kidney impairment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Haartmaninkatu 400029 HelsinkiFinland
Open in maps ↗
Recruiting now
no trials
Conditions studied
4

More sites in HelsinkiFinland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 1 diabetes mellitus+1

Not yet recruiting

Dapagliflozin and SC0062 in adults with type 1 diabetes and chronic kidney disease: effect on albuminuria in a Phase 2 randomized trial

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

Hormone-refractory prostate cancer+1

Not recruiting

Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.